Core module biomarker identification with network exploration for breast cancer metastasis

<p>Abstract</p> <p>Background</p> <p>In a complex disease, the expression of many genes can be significantly altered, leading to the appearance of a differentially expressed "disease module". Some of these genes directly correspond to the disease phenotype, (i...

Full description

Bibliographic Details
Main Authors: Yang Ruoting, Daigle Bernie J, Petzold Linda R, Doyle Francis J
Format: Article
Language:English
Published: BMC 2012-01-01
Series:BMC Bioinformatics
Online Access:http://www.biomedcentral.com/1471-2105/13/12
_version_ 1818646206134353920
author Yang Ruoting
Daigle Bernie J
Petzold Linda R
Doyle Francis J
author_facet Yang Ruoting
Daigle Bernie J
Petzold Linda R
Doyle Francis J
author_sort Yang Ruoting
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>In a complex disease, the expression of many genes can be significantly altered, leading to the appearance of a differentially expressed "disease module". Some of these genes directly correspond to the disease phenotype, (i.e. "driver" genes), while others represent closely-related first-degree neighbours in gene interaction space. The remaining genes consist of further removed "passenger" genes, which are often not directly related to the original cause of the disease. For prognostic and diagnostic purposes, it is crucial to be able to separate the group of "driver" genes and their first-degree neighbours, (i.e. "core module") from the general "disease module".</p> <p>Results</p> <p>We have developed COMBINER: COre Module Biomarker Identification with Network ExploRation. COMBINER is a novel pathway-based approach for selecting highly reproducible discriminative biomarkers. We applied COMBINER to three benchmark breast cancer datasets for identifying prognostic biomarkers. COMBINER-derived biomarkers exhibited 10-fold higher reproducibility than other methods, with up to 30-fold greater enrichment for known cancer-related genes, and 4-fold enrichment for known breast cancer susceptible genes. More than 50% and 40% of the resulting biomarkers were cancer and breast cancer specific, respectively. The identified modules were overlaid onto a map of intracellular pathways that comprehensively highlighted the hallmarks of cancer. Furthermore, we constructed a global regulatory network intertwining several functional clusters and uncovered 13 confident "driver" genes of breast cancer metastasis.</p> <p>Conclusions</p> <p>COMBINER can efficiently and robustly identify disease core module genes and construct their associated regulatory network. In the same way, it is potentially applicable in the characterization of any disease that can be probed with microarrays.</p>
first_indexed 2024-12-17T00:42:57Z
format Article
id doaj.art-712bc04edb8b4815b87820b2e3733d66
institution Directory Open Access Journal
issn 1471-2105
language English
last_indexed 2024-12-17T00:42:57Z
publishDate 2012-01-01
publisher BMC
record_format Article
series BMC Bioinformatics
spelling doaj.art-712bc04edb8b4815b87820b2e3733d662022-12-21T22:09:59ZengBMCBMC Bioinformatics1471-21052012-01-011311210.1186/1471-2105-13-12Core module biomarker identification with network exploration for breast cancer metastasisYang RuotingDaigle Bernie JPetzold Linda RDoyle Francis J<p>Abstract</p> <p>Background</p> <p>In a complex disease, the expression of many genes can be significantly altered, leading to the appearance of a differentially expressed "disease module". Some of these genes directly correspond to the disease phenotype, (i.e. "driver" genes), while others represent closely-related first-degree neighbours in gene interaction space. The remaining genes consist of further removed "passenger" genes, which are often not directly related to the original cause of the disease. For prognostic and diagnostic purposes, it is crucial to be able to separate the group of "driver" genes and their first-degree neighbours, (i.e. "core module") from the general "disease module".</p> <p>Results</p> <p>We have developed COMBINER: COre Module Biomarker Identification with Network ExploRation. COMBINER is a novel pathway-based approach for selecting highly reproducible discriminative biomarkers. We applied COMBINER to three benchmark breast cancer datasets for identifying prognostic biomarkers. COMBINER-derived biomarkers exhibited 10-fold higher reproducibility than other methods, with up to 30-fold greater enrichment for known cancer-related genes, and 4-fold enrichment for known breast cancer susceptible genes. More than 50% and 40% of the resulting biomarkers were cancer and breast cancer specific, respectively. The identified modules were overlaid onto a map of intracellular pathways that comprehensively highlighted the hallmarks of cancer. Furthermore, we constructed a global regulatory network intertwining several functional clusters and uncovered 13 confident "driver" genes of breast cancer metastasis.</p> <p>Conclusions</p> <p>COMBINER can efficiently and robustly identify disease core module genes and construct their associated regulatory network. In the same way, it is potentially applicable in the characterization of any disease that can be probed with microarrays.</p>http://www.biomedcentral.com/1471-2105/13/12
spellingShingle Yang Ruoting
Daigle Bernie J
Petzold Linda R
Doyle Francis J
Core module biomarker identification with network exploration for breast cancer metastasis
BMC Bioinformatics
title Core module biomarker identification with network exploration for breast cancer metastasis
title_full Core module biomarker identification with network exploration for breast cancer metastasis
title_fullStr Core module biomarker identification with network exploration for breast cancer metastasis
title_full_unstemmed Core module biomarker identification with network exploration for breast cancer metastasis
title_short Core module biomarker identification with network exploration for breast cancer metastasis
title_sort core module biomarker identification with network exploration for breast cancer metastasis
url http://www.biomedcentral.com/1471-2105/13/12
work_keys_str_mv AT yangruoting coremodulebiomarkeridentificationwithnetworkexplorationforbreastcancermetastasis
AT daigleberniej coremodulebiomarkeridentificationwithnetworkexplorationforbreastcancermetastasis
AT petzoldlindar coremodulebiomarkeridentificationwithnetworkexplorationforbreastcancermetastasis
AT doylefrancisj coremodulebiomarkeridentificationwithnetworkexplorationforbreastcancermetastasis